Crown Electrokinetics (CRKN)
(Delayed Data from NSDQ)
$0.05 USD
0.00 (1.80%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.05 0.00 (-1.77%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Crown Electrokinetics Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 1 | 0 | 0 | 0 | 1 |
Gross Profit | -1 | 0 | 0 | 0 | -1 |
Selling & Adminstrative & Depr. & Amort Expenses | 19 | 15 | 0 | 19 | 7 |
Income After Depreciation & Amortization | -19 | -15 | 0 | -19 | -8 |
Non-Operating Income | 0 | 1 | 0 | -18 | 0 |
Interest Expense | 9 | 0 | 0 | 3 | 2 |
Pretax Income | -29 | -14 | 0 | -41 | -10 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -29 | -14 | 0 | -41 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -29 | -14 | 0 | -41 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -14 | 0 | -17 | -7 |
Depreciation & Amortization (Cash Flow) | 11 | 1 | 0 | 3 | 1 |
Income After Depreciation & Amortization | -19 | -15 | 0 | -19 | -8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 5.43 | 2.91 | NA | 1.48 | NA |
Diluted EPS Before Non-Recurring Items | -4.15 | -4.92 | -8.10 | -17.52 | NA |
Diluted Net EPS (GAAP) | -5.46 | -4.92 | -18.18 | -27.59 | -4.68 |
Fiscal Year end for Crown Electrokinetics Corp falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.09 | 0.00 | 0.04 | 0.02 |
Cost Of Goods | NA | 0.83 | 0.00 | 0.02 | 0.03 |
Gross Profit | NA | -0.74 | 0.00 | 0.01 | -0.01 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.13 | 3.43 | 4.90 | 4.12 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.87 | -3.43 | -4.89 | -4.13 |
Non-Operating Income | NA | 0.00 | 3.02 | -7.13 | 3.84 |
Interest Expense | NA | 2.45 | 2.45 | 2.51 | 2.02 |
Pretax Income | NA | -9.31 | -2.86 | -14.52 | -2.30 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -9.31 | -2.86 | -14.52 | -2.30 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -9.31 | -2.86 | -14.52 | -2.30 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 3.35 | 0.81 | 4.95 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.94 | -9.27 | -0.48 |
Diluted Net EPS (GAAP) | NA | 13.98 | -0.94 | -18.02 | -0.48 |